Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Rectal Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Rectal Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Rectal Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Rectal Cancer 31
Sep 30, 2019: Adlai Nortye presents encouraging phase 1b study data of AN0025 (an Oral EP4 Antagonist) for locally advanced rectal cancer at ESMO 2019 31
Clinical Trial Profile Snapshots 32
Appendix 712
Abbreviations 712
Definitions 712
Research Methodology 713
Secondary Research 713
About GlobalData 714
Contact Us 714
Disclaimer 714
Source 715
Rectal Cancer Therapeutics, Global, Clinical Trials by Region, 2019* 8
Rectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Rectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Rectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 11
Rectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 12
Rectal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019* 13
Rectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 14
Rectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 15
Proportion of Rectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Rectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Rectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Rectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Rectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Rectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Rectal Cancer Therapeutics, Global, Clinical Trials by Phase, 2019* 22
Rectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 23
Rectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Rectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Rectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Rectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 27
Rectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Rectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Rectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
List of Figures
Rectal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Rectal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Rectal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 10
Rectal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 11
Rectal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 12
Rectal Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 13
Rectal Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 14
Rectal Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 15
Proportion of Rectal Cancer to Oncology Clinical Trials, G7 Countries (%), 2019* 16
Rectal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 17
Rectal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 18
Proportion of Rectal Cancer to Oncology Clinical Trials, E7 Countries (%), 2019* 19
Rectal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 20
Rectal Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 21
Rectal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019* 22
Rectal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 23
Rectal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019* 24
Rectal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019* 25
Rectal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 26
Rectal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 27
Rectal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 28
Rectal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 29
Rectal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 30
GlobalData Methodology 713
【免責事項】
https://www.marketreport.jp/reports-disclaimer